Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody

NCT01430429 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG: NI-0801

Sponsor

Light Chain Bioscience - Novimmune SA